Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 6, 2026

5 hours ago

VivoSim Provides Financial and Listing Compliance Update

Indeterminate GlobeNewswire

5 hours ago

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

Indeterminate GlobeNewswire

5 hours ago

Medecision Earns “Innovators” Distinction in Frost & Sullivan’s 2026 Frost Radar™ Report

Indeterminate GlobeNewswire

5 hours ago

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

5 hours ago

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Indeterminate GlobeNewswire

5 hours ago

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Indeterminate GlobeNewswire

5 hours ago

vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026

Indeterminate GlobeNewswire

5 hours ago

Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

5 hours ago

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Indeterminate GlobeNewswire

5 hours ago

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Indeterminate GlobeNewswire

5 hours ago

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

5 hours ago

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire

5 hours ago

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

5 hours ago

MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

5 hours ago

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan

Indeterminate GlobeNewswire

5 hours ago

PwC and Zyter Collaborate to Help Healthcare Organizations Transform Total Cost of Care and Improve Measurable Outcomes

Indeterminate GlobeNewswire

5 hours ago

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

Indeterminate GlobeNewswire

5 hours ago

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Indeterminate GlobeNewswire